Page last updated: 2024-08-17

quinoxalines and Hyperactivity, Motor

quinoxalines has been researched along with Hyperactivity, Motor in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arnoux, I; Barger, Z; Bittner, S; Ellwardt, E; Jubal, ER; Kuhlmann, T; Luchtman, D; Lutz, B; Mandal, S; Mittmann, T; Novkovic, T; Pramanik, G; Ruiz de Azua, I; Schmalz, M; Stroh, A; Vogelaar, CF; Vogt, J; Zipp, F1
Camarasa, J; Ciudad-Roberts, A; Escubedo, E; Pubill, D1
Ago, Y; Araki, R; Hasebe, S; Matsuda, T; Nishiyama, S; Oka, S; Takuma, K; Tanaka, T1
Chan, MH; Chen, HH; Chien, TH; Lee, PY1
Carlsson, A; Carlsson, ML; Martin, P; Waters, N; Waters, S1

Other Studies

5 other study(ies) available for quinoxalines and Hyperactivity, Motor

ArticleYear
Maladaptive cortical hyperactivity upon recovery from experimental autoimmune encephalomyelitis.
    Nature neuroscience, 2018, Volume: 21, Issue:10

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Cells, Cultured; Cerebral Cortex; Cuprizone; Disease Models, Animal; Egtazic Acid; Encephalomyelitis, Autoimmune, Experimental; Excitatory Amino Acid Antagonists; Female; Freund's Adjuvant; Hyperkinesis; Membrane Potentials; Mice; Mice, Transgenic; Microglia; Myelin Proteolipid Protein; Peptide Fragments; Proto-Oncogene Proteins c-fos; Quinoxalines; Recovery of Function; Sodium Channel Blockers; Tetrodotoxin

2018
Heteromeric nicotinic receptors are involved in the sensitization and addictive properties of MDMA in mice.
    Progress in neuro-psychopharmacology & biological psychiatry, 2013, Jul-01, Volume: 44

    Topics: Analysis of Variance; Animals; Benzazepines; Brain; Cholinergic Agents; Conditioning, Operant; Dihydro-beta-Erythroidine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Hallucinogens; Hyperkinesis; Male; Mice; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Protein Binding; Quinoxalines; Radionuclide Imaging; Receptors, Nicotinic; Substance-Related Disorders; Tritium; Varenicline

2013
Involvement of prefrontal AMPA receptors in encounter stimulation-induced hyperactivity in isolation-reared mice.
    The international journal of neuropsychopharmacology, 2014, Volume: 17, Issue:6

    Topics: Aggression; Animals; Animals, Outbred Strains; Cognition Disorders; Depression; Dopamine; Excitatory Amino Acid Antagonists; Hippocampus; Hyperkinesis; Male; Mice; Nucleus Accumbens; Prefrontal Cortex; Quinoxalines; Receptors, AMPA; Serotonin; Social Behavior; Social Isolation

2014
Involvement of NO/cGMP pathway in toluene-induced locomotor hyperactivity in female rats.
    Psychopharmacology, 2004, Volume: 176, Issue:3-4

    Topics: Animals; Arginine; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Guanylate Cyclase; Hyperkinesis; Injections, Intraperitoneal; Motor Activity; Nerve Tissue Proteins; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitroprusside; Oxadiazoles; Quinoxalines; Rats; Rats, Sprague-Dawley; Signal Transduction; Toluene

2004
MK-801-induced hyperlocomotion: differential effects of M100907, SDZ PSD 958 and raclopride.
    European journal of pharmacology, 1997, Sep-24, Volume: 335, Issue:2-3

    Topics: Animals; Dizocilpine Maleate; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Fluorobenzenes; Hyperkinesis; Male; Mice; Motor Activity; Piperidines; Quinoxalines; Raclopride; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D1; Receptors, Serotonin; Salicylamides; Serotonin Antagonists

1997